# Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ns-28-007-network-for-excellence-in-neuroscience-clinical-trials/  
Official notice: https://www.grants.gov/search-results-detail/363835

> National Institutes of Health plans to offer grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It is a forecast: the notice is expected around September 1, 2027, with applications due around November 1, 2027.

| Field | Value |
|---|---|
| Opportunity number | RFA-NS-28-007 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | expected November 1, 2027 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.853 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.

## What the grant funds

The National Institute of Neurological Disorders and Stroke (NINDS), at the National Institutes of Health (NIH) seek to continue support for the Infrastructure for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT). NeuroNEXT conducts clinical trials and biomarker validation studies for neurological disorders in adult and pediatric populations. By offering infrastructure, expertise, and collaborative opportunities, NeuroNEXT accelerates innovation and impact, advancing the development of safe, effective neurotherapeutics for patients through high-quality evidence pathways. The program will encourage applications for network clinical research sites to support NeuroNEXT. Applications are not being solicited at this time. This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications for clinical research sites.

## Questions people ask

### Who can apply for Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed)?

National Institutes of Health accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed)?

Expected deadline November 1, 2027. Confirm the date and time in the official notice on Grants.gov.